Delivery Order SPE2DB20D3103-SPE2DB25FP4V7

Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $5,862.00, with a Firm Fixed Price pricing type. The contract provides for the delivery of 36,000 units of CREON DR 100S capsules by June 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.63 delivery order contract is for the provision of 36,000 unit capsules of the medication Creon DR, with a completion date of April 18, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,206.64 firm fixed-price delivery order is for the supply of 36,000 units of a pharmaceutical product, CREON DR 36,000 UNIT CAPSULE. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,793.75, is a Firm Fixed Price Delivery Order for the supply of 36,000 unit capsules of the drug CREON DR. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $11,333.21 firm fixed-price delivery order is for the supply of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S. The contract has a completion date of March 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,467.83, is a delivery order for 4,567,142,450 units of a 3,000 unit capsule product (CREON DR) over a term ending on February 5, 2025. The contract is a firm fixed price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a large Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,889.50, is for the delivery of 36,000 unit capsules of the medical product Creon DR. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. This award is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.12 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 20, 2025. It covers the provision of 24,000 unit capsules of the drug CREON DR. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,715.77 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the product "CREON DR" and has a completion date of July 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,746.42 firm-fixed-price delivery order contract is for the procurement of 24,000 unit capsules of the product "CREON DR 24,000 UNIT CAPSULE UU 100S." The contract has an ultimate completion date of July 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP4V7
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $15,204.58, for the delivery of 12,000 unit capsules of the product CREON DR. The contract has an ultimate completion date of July 14, 2025.

Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 10/12/25, 1:18 AM